Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-trace').style.display = (document.getElementById('cakeErr6800920ba8364-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6800920ba8364-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-code').style.display = (document.getElementById('cakeErr6800920ba8364-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-context').style.display = (document.getElementById('cakeErr6800920ba8364-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6800920ba8364-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6800920ba8364-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16860,
		&#039;title&#039; =&gt; &#039;Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;img src=&quot;tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16988,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16860,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times





India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;img src=&quot;https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16860,
	&#039;title&#039; =&gt; &#039;Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;img src=&quot;tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16988,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16860
$metaTitle = &#039;LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Economic Times





India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;img src=&quot;https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh | Im4change.org</title>
    <meta name="description" content="
-The Economic Times





India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pricing of imported drugs under regulatory scanner-Khomba Singh</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Economic Times</div><div style="text-align: justify"><img src="https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp" alt="Medicines" /></div><div style="text-align: justify">India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.</div><div style="text-align: justify"><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-trace').style.display = (document.getElementById('cakeErr6800920ba8364-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6800920ba8364-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-code').style.display = (document.getElementById('cakeErr6800920ba8364-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-context').style.display = (document.getElementById('cakeErr6800920ba8364-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6800920ba8364-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6800920ba8364-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16860,
		&#039;title&#039; =&gt; &#039;Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;img src=&quot;tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16988,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16860,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times





India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;img src=&quot;https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16860,
	&#039;title&#039; =&gt; &#039;Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;img src=&quot;tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16988,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16860
$metaTitle = &#039;LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Economic Times





India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;img src=&quot;https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh | Im4change.org</title>
    <meta name="description" content="
-The Economic Times





India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pricing of imported drugs under regulatory scanner-Khomba Singh</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Economic Times</div><div style="text-align: justify"><img src="https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp" alt="Medicines" /></div><div style="text-align: justify">India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.</div><div style="text-align: justify"><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-trace').style.display = (document.getElementById('cakeErr6800920ba8364-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6800920ba8364-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-code').style.display = (document.getElementById('cakeErr6800920ba8364-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6800920ba8364-context').style.display = (document.getElementById('cakeErr6800920ba8364-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6800920ba8364-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr6800920ba8364-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16860,
		&#039;title&#039; =&gt; &#039;Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;img src=&quot;tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 16988,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16860,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Economic Times





India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;img src=&quot;https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16860,
	&#039;title&#039; =&gt; &#039;Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Economic Times
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;img src=&quot;tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 16988,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16860
$metaTitle = &#039;LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh&#039;
$metaKeywords = &#039;medicines,Health&#039;
$metaDesc = &#039;
-The Economic Times





India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Economic Times&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;img src=&quot;https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp&quot; alt=&quot;Medicines&quot; /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&#039;s drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&amp;quot; Singh said. &amp;quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&amp;quot;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &amp;quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&amp;quot; said Rakesh Bamzai, president (marketing), at Biocon.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA&#039;s move contradicts the department of pharmaceuticals&#039; policy.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of &#039;cost-based pricing&#039; for imported products, when the department of pharmaceuticals, on the contrary, recommends &#039;market-based pricing&#039; in its draft National Pharmaceutical Pricing Policy 2011,&amp;quot; Tapan Ray, director-general of the organisation, said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&amp;quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh | Im4change.org</title>
    <meta name="description" content="
-The Economic Times





India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Pricing of imported drugs under regulatory scanner-Khomba Singh</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Economic Times</div><div style="text-align: justify"><img src="https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp" alt="Medicines" /></div><div style="text-align: justify">India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.</div><div style="text-align: justify"><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 16860,
		'title' => 'Pricing of imported drugs under regulatory scanner-Khomba Singh',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
-The Economic Times
</div>
<div style="text-align: justify">
<img src="tinymce/uploaded/Medicines_1.bmp" alt="Medicines" />
</div>
<div style="text-align: justify">
India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
</div>
<div style="text-align: justify">
<br />
</div>',
		'credit_writer' => 'The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 16988,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 16860,
	'metaTitle' => 'LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh',
	'metaKeywords' => 'medicines,Health',
	'metaDesc' => '
-The Economic Times





India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...',
	'disp' => '<div style="text-align: justify">-The Economic Times</div><div style="text-align: justify"><img src="https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp" alt="Medicines" /></div><div style="text-align: justify">India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.</div><div style="text-align: justify"><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 16860,
	'title' => 'Pricing of imported drugs under regulatory scanner-Khomba Singh',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
-The Economic Times
</div>
<div style="text-align: justify">
<img src="tinymce/uploaded/Medicines_1.bmp" alt="Medicines" />
</div>
<div style="text-align: justify">
India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.
</div>
<div style="text-align: justify">
<br />
</div>',
	'credit_writer' => 'The Economic Times, 6 September, 2012, http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'pricing-of-imported-drugs-under-regulatory-scanner-khomba-singh-16988',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 16988,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 16860
$metaTitle = 'LATEST NEWS UPDATES | Pricing of imported drugs under regulatory scanner-Khomba Singh'
$metaKeywords = 'medicines,Health'
$metaDesc = '
-The Economic Times





India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.





The National Pharmaceutical Pricing Authority (NPPA) has written to...'
$disp = '<div style="text-align: justify">-The Economic Times</div><div style="text-align: justify"><img src="https://im4change.in/siteadmin/tinymce/uploaded/Medicines_1.bmp" alt="Medicines" /></div><div style="text-align: justify">India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug),&quot; Singh said. &quot;We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price.&quot;</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. &quot;We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage,&quot; said Rakesh Bamzai, president (marketing), at Biocon.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011,&quot; Tapan Ray, director-general of the organisation, said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&quot;It will signal utter confusion in the pharmaceutical policy making process of the government,&quot; he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.</div><div style="text-align: justify"><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Pricing of imported drugs under regulatory scanner-Khomba Singh

-The Economic Times India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country. The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET. The amendment will allow NPPA to seek details of the methodology adopted by importers to arrive at the landed price of drugs on the basis of which the maximum retail prices of imported drugs are fixed. The DPCO does not allow NPPA to seek such details. The regulator has to go by the landed cost declared by the importer, limiting its pricing authority to merely fixing the profit margin. "There is an impression among some quarters that some companies are launching their drugs in India by declaring a much higher price (than cost of the drug)," Singh said. "We want to have some control over this in public interest. Today, we are completely blind how they have arrived at the landed price." Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug. Last year, NPPA tried to seek such details from some foreign drug makers. But its request was shot down by the Delhi High Court after the law ministry conceded that NPPA had no such powers under DPCO. Local companies also say this rule is unfair to them as their MRP is fixed after strict scrutiny of the cost of production by NPPA, while no such rule is applicable to imported brands. "We want a level playing field based on a common ceiling price for a product to encourage domestic manufacturers by ensuring that imported products do not get an unfair advantage," said Rakesh Bamzai, president (marketing), at Biocon. The market for imported medicines has trebled to Rs 11,113 crore in the past eight financial years, according to CMIE data. The share of drugs under price control, however, will be small as NPPA regulates prices of medicines made using 74 ingredients alone, which accounts for 20% of the market. But the Organisation of Pharmaceutical Producers of India, a representative body of MNC drug firms, said NPPA's move contradicts the department of pharmaceuticals' policy. "The recommendation of the NPPA is tantamount to facilitating back-door entry of 'cost-based pricing' for imported products, when the department of pharmaceuticals, on the contrary, recommends 'market-based pricing' in its draft National Pharmaceutical Pricing Policy 2011," Tapan Ray, director-general of the organisation, said. "It will signal utter confusion in the pharmaceutical policy making process of the government," he said, adding that such recommendations from NPPA will signal a high degree of unpredictability in the pharmaceuticals business environment. A group of ministers, led by agriculture minister Sharad Pawar, is in the process of finalising a drug pricing policy, which seeks to fix prices of 348 drugs. The department of pharmaceuticals has proposed a market-based pricing mechanism, although it is opposed by the health ministry, NGOs and some members of Parliament. The debate on the issue began last year after NPPA refused to hike prices of imported brands of US-based Eli Lilly. It also rejected to revise prices of insulin brands of all drug makers citing public interest. Companies have alleged that their margins were squeezed to as low as 5% and it was becoming difficult for them to do business under such strict regulation.